APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmology AI Screening Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ophthalmology AI Screening Software Market Outlook and Growth Opportunities 2026

3 March 2026209 pages

Choose your research edition.

Industry ResearchOphthalmology AI Screening Software Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmology AI Screening Software Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Ophthalmology AI Screening Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmology AI Screening Software Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmology AI Screening Software Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Ophthalmology AI Screening Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ophthalmology AI Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmology AI Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmology AI Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ophthalmology AI Screening Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ophthalmology AI Screening Software market include Eyenuk, Inc., DeepMind, Remidio, Retmarker, AEYE Health, RetinaLyze, Synapxe, Intelligent Retinal Imaging Systems and RetinAI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ophthalmology AI Screening Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmology AI Screening Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmology AI Screening Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ophthalmology AI Screening Software market.

Ophthalmology AI Screening Software Segment by Company

Eyenuk, Inc.

DeepMind

Remidio

Retmarker

AEYE Health

RetinaLyze

Synapxe

Intelligent Retinal Imaging Systems

RetinAI

RetinaRisk

CSIRO

Airdoc

Silicon Intelligence

Zhiyuan Huitu

WeDoctor Group

VoxelCloud

Kangfuzi Health

Zhenhealth

Tencent Health

Ophthalmology AI Screening Software Segment by Type

On-premises

Cloud-based

Ophthalmology AI Screening Software Segment by Application

Hospital

Eye Clinic

Medical Research

Others

Ophthalmology AI Screening Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ophthalmology AI Screening Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ophthalmology AI Screening Software key companies, revenue, market share, and recent developments.

3. To split the Ophthalmology AI Screening Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ophthalmology AI Screening Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ophthalmology AI Screening Software significant trends, drivers, influence factors in global and regions.

6. To analyze Ophthalmology AI Screening Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmology AI Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmology AI Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmology AI Screening Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmology AI Screening Software industry.

Chapter 3: Detailed analysis of Ophthalmology AI Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ophthalmology AI Screening Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ophthalmology AI Screening Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ophthalmology AI Screening Software Industry Trends Table 2. Ophthalmology AI Screening Software Industry Drivers Table 3. Ophthalmology AI Screening Software Industry Opportunities and Challenges Table 4. Ophthalmology AI Screening Software Industry Restraints Table 5. Global Ophthalmology AI Screening Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ophthalmology AI Screening Software Revenue Share by Company (2021-2026) Table 7. Global Ophthalmology AI Screening Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ophthalmology AI Screening Software Key Company Manufacturing Base & Headquarters Table 9. Global Ophthalmology AI Screening Software Company, Product Type & Application Table 10. Global Ophthalmology AI Screening Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ophthalmology AI Screening Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-premises Table 15. Significant Companies of Cloud-based Table 16. Global Ophthalmology AI Screening Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Ophthalmology AI Screening Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Ophthalmology AI Screening Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Ophthalmology AI Screening Software Sales Value Share by Type (2021-2026) Table 20. Global Ophthalmology AI Screening Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Eye Clinic Table 23. Significant Companies of Medical Research Table 24. Significant Companies of Others Table 25. Global Ophthalmology AI Screening Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ophthalmology AI Screening Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Ophthalmology AI Screening Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Ophthalmology AI Screening Software Sales Value Share by Application (2021-2026) Table 29. Global Ophthalmology AI Screening Software Sales Value Share by Application (2027-2032) Table 30. Global Ophthalmology AI Screening Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ophthalmology AI Screening Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Ophthalmology AI Screening Software Sales Value Share by Region (2021-2026) Table 33. Global Ophthalmology AI Screening Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Ophthalmology AI Screening Software Sales Value Share by Region (2027-2032) Table 35. Global Ophthalmology AI Screening Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Ophthalmology AI Screening Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Ophthalmology AI Screening Software Sales Value Market Share by Country (2021-2026) Table 38. Global Ophthalmology AI Screening Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Ophthalmology AI Screening Software Sales Value Market Share by Country (2027-2032) Table 40. Eyenuk, Inc. Company Information Table 41. Eyenuk, Inc. Business Overview Table 42. Eyenuk, Inc. Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Eyenuk, Inc. Ophthalmology AI Screening Software Product Portfolio Table 44. Eyenuk, Inc. Recent Development Table 45. DeepMind Company Information Table 46. DeepMind Business Overview Table 47. DeepMind Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. DeepMind Ophthalmology AI Screening Software Product Portfolio Table 49. DeepMind Recent Development Table 50. Remidio Company Information Table 51. Remidio Business Overview Table 52. Remidio Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Remidio Ophthalmology AI Screening Software Product Portfolio Table 54. Remidio Recent Development Table 55. Retmarker Company Information Table 56. Retmarker Business Overview Table 57. Retmarker Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Retmarker Ophthalmology AI Screening Software Product Portfolio Table 59. Retmarker Recent Development Table 60. AEYE Health Company Information Table 61. AEYE Health Business Overview Table 62. AEYE Health Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. AEYE Health Ophthalmology AI Screening Software Product Portfolio Table 64. AEYE Health Recent Development Table 65. RetinaLyze Company Information Table 66. RetinaLyze Business Overview Table 67. RetinaLyze Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. RetinaLyze Ophthalmology AI Screening Software Product Portfolio Table 69. RetinaLyze Recent Development Table 70. Synapxe Company Information Table 71. Synapxe Business Overview Table 72. Synapxe Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Synapxe Ophthalmology AI Screening Software Product Portfolio Table 74. Synapxe Recent Development Table 75. Intelligent Retinal Imaging Systems Company Information Table 76. Intelligent Retinal Imaging Systems Business Overview Table 77. Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Product Portfolio Table 79. Intelligent Retinal Imaging Systems Recent Development Table 80. RetinAI Company Information Table 81. RetinAI Business Overview Table 82. RetinAI Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. RetinAI Ophthalmology AI Screening Software Product Portfolio Table 84. RetinAI Recent Development Table 85. RetinaRisk Company Information Table 86. RetinaRisk Business Overview Table 87. RetinaRisk Ophthalmology AI Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. RetinaRisk Ophthalmology AI Screening Software Product Portfolio Table 89. RetinaRisk Recent Development Table 90. CSIRO Company Information Table 91. CSIRO Business Overview Table 92. CSIRO Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CSIRO Ophthalmology AI Screening Software Product Portfolio Table 94. CSIRO Recent Development Table 95. Airdoc Company Information Table 96. Airdoc Business Overview Table 97. Airdoc Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Airdoc Ophthalmology AI Screening Software Product Portfolio Table 99. Airdoc Recent Development Table 100. Silicon Intelligence Company Information Table 101. Silicon Intelligence Business Overview Table 102. Silicon Intelligence Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Silicon Intelligence Ophthalmology AI Screening Software Product Portfolio Table 104. Silicon Intelligence Recent Development Table 105. Zhiyuan Huitu Company Information Table 106. Zhiyuan Huitu Business Overview Table 107. Zhiyuan Huitu Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Zhiyuan Huitu Ophthalmology AI Screening Software Product Portfolio Table 109. Zhiyuan Huitu Recent Development Table 110. WeDoctor Group Company Information Table 111. WeDoctor Group Business Overview Table 112. WeDoctor Group Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. WeDoctor Group Ophthalmology AI Screening Software Product Portfolio Table 114. WeDoctor Group Recent Development Table 115. VoxelCloud Company Information Table 116. VoxelCloud Business Overview Table 117. VoxelCloud Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. VoxelCloud Ophthalmology AI Screening Software Product Portfolio Table 119. VoxelCloud Recent Development Table 120. Kangfuzi Health Company Information Table 121. Kangfuzi Health Business Overview Table 122. Kangfuzi Health Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Kangfuzi Health Ophthalmology AI Screening Software Product Portfolio Table 124. Kangfuzi Health Recent Development Table 125. Zhenhealth Company Information Table 126. Zhenhealth Business Overview Table 127. Zhenhealth Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Zhenhealth Ophthalmology AI Screening Software Product Portfolio Table 129. Zhenhealth Recent Development Table 130. Tencent Health Company Information Table 131. Tencent Health Business Overview Table 132. Tencent Health Ophthalmology AI Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Tencent Health Ophthalmology AI Screening Software Product Portfolio Table 134. Tencent Health Recent Development Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Ophthalmology AI Screening Software Product Image Figure 2. Global Ophthalmology AI Screening Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmology AI Screening Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmology AI Screening Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-premises Image Figure 8. Cloud-based Image Figure 9. Global Ophthalmology AI Screening Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Ophthalmology AI Screening Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Ophthalmology AI Screening Software Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Eye Clinic Image Figure 14. Medical Research Image Figure 15. Others Image Figure 16. Global Ophthalmology AI Screening Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ophthalmology AI Screening Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Ophthalmology AI Screening Software Sales Value Share by Application (2021-2032) Figure 19. Global Ophthalmology AI Screening Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Ophthalmology AI Screening Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Ophthalmology AI Screening Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Ophthalmology AI Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Ophthalmology AI Screening Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Ophthalmology AI Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Ophthalmology AI Screening Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Ophthalmology AI Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Ophthalmology AI Screening Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Ophthalmology AI Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Ophthalmology AI Screening Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Ophthalmology AI Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • On-premises
  • Cloud-based
Applications
  • Hospital
  • Eye Clinic
  • Medical Research
  • Others
Companies covered
  • Eyenuk, Inc.
  • DeepMind
  • Remidio
  • Retmarker
  • AEYE Health
  • RetinaLyze
  • Synapxe
  • Intelligent Retinal Imaging Systems
  • RetinAI
  • RetinaRisk
  • CSIRO
  • Airdoc
  • Silicon Intelligence
  • Zhiyuan Huitu
  • WeDoctor Group
  • VoxelCloud
  • Kangfuzi Health
  • Zhenhealth
  • Tencent Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ophthalmology AI Screening Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ophthalmology AI Screening Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ophthalmology AI Screening Software Market Dynamics
  1. 2.1 Ophthalmology AI Screening Software Industry Trends
  2. 2.2 Ophthalmology AI Screening Software Industry Drivers
  3. 2.3 Ophthalmology AI Screening Software Industry Opportunities and Challenges
  4. 2.4 Ophthalmology AI Screening Software Industry Restraints
3 Ophthalmology AI Screening Software Market by Company
  1. 3.1 Global Ophthalmology AI Screening Software Company Revenue Ranking in 2025
  2. 3.2 Global Ophthalmology AI Screening Software Revenue by Company (2021-2026)
  3. 3.3 Global Ophthalmology AI Screening Software Company Ranking (2024-2026)
  4. 3.4 Global Ophthalmology AI Screening Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Ophthalmology AI Screening Software Company Product Type and Application
  6. 3.6 Global Ophthalmology AI Screening Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ophthalmology AI Screening Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ophthalmology AI Screening Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ophthalmology AI Screening Software Market by Type
  1. 4.1 Ophthalmology AI Screening Software Type Introduction
  2. 4.1.1 On-premises
  3. 4.1.2 Cloud-based
  4. 4.2 Global Ophthalmology AI Screening Software Sales Value by Type
  5. 4.2.1 Global Ophthalmology AI Screening Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ophthalmology AI Screening Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Ophthalmology AI Screening Software Sales Value Share by Type (2021-2032)
5 Ophthalmology AI Screening Software Market by Application
  1. 5.1 Ophthalmology AI Screening Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Eye Clinic
  4. 5.1.3 Medical Research
  5. 5.1.4 Others
  6. 5.2 Global Ophthalmology AI Screening Software Sales Value by Application
  7. 5.2.1 Global Ophthalmology AI Screening Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ophthalmology AI Screening Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global Ophthalmology AI Screening Software Sales Value Share by Application (2021-2032)
6 Ophthalmology AI Screening Software Regional Value Analysis
  1. 6.1 Global Ophthalmology AI Screening Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmology AI Screening Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ophthalmology AI Screening Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ophthalmology AI Screening Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ophthalmology AI Screening Software Sales Value (2021-2032)
  7. 6.3.2 North America Ophthalmology AI Screening Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ophthalmology AI Screening Software Sales Value (2021-2032)
  10. 6.4.2 Europe Ophthalmology AI Screening Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ophthalmology AI Screening Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ophthalmology AI Screening Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ophthalmology AI Screening Software Sales Value (2021-2032)
  16. 6.6.2 South America Ophthalmology AI Screening Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ophthalmology AI Screening Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ophthalmology AI Screening Software Sales Value Share by Country, 2025 VS 2032
7 Ophthalmology AI Screening Software Country-level Value Analysis
  1. 7.1 Global Ophthalmology AI Screening Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ophthalmology AI Screening Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ophthalmology AI Screening Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ophthalmology AI Screening Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ophthalmology AI Screening Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ophthalmology AI Screening Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ophthalmology AI Screening Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eyenuk, Inc.
  2. 8.1.1 Eyenuk, Inc. Company Information
  3. 8.1.2 Eyenuk, Inc. Business Overview
  4. 8.1.3 Eyenuk, Inc. Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eyenuk, Inc. Ophthalmology AI Screening Software Product Portfolio
  6. 8.1.5 Eyenuk, Inc. Recent Developments
  7. 8.2 DeepMind
  8. 8.2.1 DeepMind Company Information
  9. 8.2.2 DeepMind Business Overview
  10. 8.2.3 DeepMind Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DeepMind Ophthalmology AI Screening Software Product Portfolio
  12. 8.2.5 DeepMind Recent Developments
  13. 8.3 Remidio
  14. 8.3.1 Remidio Company Information
  15. 8.3.2 Remidio Business Overview
  16. 8.3.3 Remidio Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Remidio Ophthalmology AI Screening Software Product Portfolio
  18. 8.3.5 Remidio Recent Developments
  19. 8.4 Retmarker
  20. 8.4.1 Retmarker Company Information
  21. 8.4.2 Retmarker Business Overview
  22. 8.4.3 Retmarker Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Retmarker Ophthalmology AI Screening Software Product Portfolio
  24. 8.4.5 Retmarker Recent Developments
  25. 8.5 AEYE Health
  26. 8.5.1 AEYE Health Company Information
  27. 8.5.2 AEYE Health Business Overview
  28. 8.5.3 AEYE Health Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AEYE Health Ophthalmology AI Screening Software Product Portfolio
  30. 8.5.5 AEYE Health Recent Developments
  31. 8.6 RetinaLyze
  32. 8.6.1 RetinaLyze Company Information
  33. 8.6.2 RetinaLyze Business Overview
  34. 8.6.3 RetinaLyze Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 RetinaLyze Ophthalmology AI Screening Software Product Portfolio
  36. 8.6.5 RetinaLyze Recent Developments
  37. 8.7 Synapxe
  38. 8.7.1 Synapxe Company Information
  39. 8.7.2 Synapxe Business Overview
  40. 8.7.3 Synapxe Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Synapxe Ophthalmology AI Screening Software Product Portfolio
  42. 8.7.5 Synapxe Recent Developments
  43. 8.8 Intelligent Retinal Imaging Systems
  44. 8.8.1 Intelligent Retinal Imaging Systems Company Information
  45. 8.8.2 Intelligent Retinal Imaging Systems Business Overview
  46. 8.8.3 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Product Portfolio
  48. 8.8.5 Intelligent Retinal Imaging Systems Recent Developments
  49. 8.9 RetinAI
  50. 8.9.1 RetinAI Company Information
  51. 8.9.2 RetinAI Business Overview
  52. 8.9.3 RetinAI Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RetinAI Ophthalmology AI Screening Software Product Portfolio
  54. 8.9.5 RetinAI Recent Developments
  55. 8.10 RetinaRisk
  56. 8.10.1 RetinaRisk Company Information
  57. 8.10.2 RetinaRisk Business Overview
  58. 8.10.3 RetinaRisk Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 RetinaRisk Ophthalmology AI Screening Software Product Portfolio
  60. 8.10.5 RetinaRisk Recent Developments
  61. 8.11 CSIRO
  62. 8.11.1 CSIRO Company Information
  63. 8.11.2 CSIRO Business Overview
  64. 8.11.3 CSIRO Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CSIRO Ophthalmology AI Screening Software Product Portfolio
  66. 8.11.5 CSIRO Recent Developments
  67. 8.12 Airdoc
  68. 8.12.1 Airdoc Company Information
  69. 8.12.2 Airdoc Business Overview
  70. 8.12.3 Airdoc Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Airdoc Ophthalmology AI Screening Software Product Portfolio
  72. 8.12.5 Airdoc Recent Developments
  73. 8.13 Silicon Intelligence
  74. 8.13.1 Silicon Intelligence Company Information
  75. 8.13.2 Silicon Intelligence Business Overview
  76. 8.13.3 Silicon Intelligence Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Silicon Intelligence Ophthalmology AI Screening Software Product Portfolio
  78. 8.13.5 Silicon Intelligence Recent Developments
  79. 8.14 Zhiyuan Huitu
  80. 8.14.1 Zhiyuan Huitu Company Information
  81. 8.14.2 Zhiyuan Huitu Business Overview
  82. 8.14.3 Zhiyuan Huitu Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zhiyuan Huitu Ophthalmology AI Screening Software Product Portfolio
  84. 8.14.5 Zhiyuan Huitu Recent Developments
  85. 8.15 WeDoctor Group
  86. 8.15.1 WeDoctor Group Company Information
  87. 8.15.2 WeDoctor Group Business Overview
  88. 8.15.3 WeDoctor Group Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 WeDoctor Group Ophthalmology AI Screening Software Product Portfolio
  90. 8.15.5 WeDoctor Group Recent Developments
  91. 8.16 VoxelCloud
  92. 8.16.1 VoxelCloud Company Information
  93. 8.16.2 VoxelCloud Business Overview
  94. 8.16.3 VoxelCloud Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 VoxelCloud Ophthalmology AI Screening Software Product Portfolio
  96. 8.16.5 VoxelCloud Recent Developments
  97. 8.17 Kangfuzi Health
  98. 8.17.1 Kangfuzi Health Company Information
  99. 8.17.2 Kangfuzi Health Business Overview
  100. 8.17.3 Kangfuzi Health Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Kangfuzi Health Ophthalmology AI Screening Software Product Portfolio
  102. 8.17.5 Kangfuzi Health Recent Developments
  103. 8.18 Zhenhealth
  104. 8.18.1 Zhenhealth Company Information
  105. 8.18.2 Zhenhealth Business Overview
  106. 8.18.3 Zhenhealth Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Zhenhealth Ophthalmology AI Screening Software Product Portfolio
  108. 8.18.5 Zhenhealth Recent Developments
  109. 8.19 Tencent Health
  110. 8.19.1 Tencent Health Company Information
  111. 8.19.2 Tencent Health Business Overview
  112. 8.19.3 Tencent Health Ophthalmology AI Screening Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Tencent Health Ophthalmology AI Screening Software Product Portfolio
  114. 8.19.5 Tencent Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst